TD Asset Management’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Hold |
|
|||||
|
2025
Q1 | $123K | Hold |
|
|||||
|
2024
Q4 | $205K | Hold |
|
|||||
|
2024
Q3 | $341K | Hold |
|
|||||
|
2024
Q2 | $612K | Hold |
|
|||||
|
2024
Q1 | $761K | Hold |
|
|||||
|
2023
Q4 | $686K | Hold |
|
|||||
|
2023
Q3 | $496K | Buy |
|
|||||
|
2023
Q2 | $361K | Buy |
|
|||||
|
2023
Q1 | $162K | Hold |
|
|||||
|
2022
Q4 | $172K | Hold |
|
|||||
|
2022
Q3 | $185K | Hold |
|
|||||
|
2022
Q2 | $148K | Hold |
|
|||||
|
2022
Q1 | $196K | Hold |
|
|||||
|
2021
Q4 | $354K | Hold |
|
|||||
|
2021
Q3 | $889K | Hold |
|
|||||
|
2021
Q2 | $911K | Hold |
|
|||||
|
2021
Q1 | $1.23M | Buy |
|
|||||
|
2020
Q4 | $1.61M | Hold |
|
|||||
|
2020
Q3 | $678K | Buy |
|